Enterococci have been recognized as human pathogens for more than a century, but only in
recent years have these organisms acquired prominence as leading causes of nosocomial …

In recent years, an increase in invasive VRE infections has been reported worldwide,
including Germany. The most common gene encoding resistance to glycopeptides is VanA …

Infections by multidrug-resistant (MDR) bacteria are a worrisome phenomenon in
hematological patients. Data on the incidence of MDR colonization and related bloodstream …

The objective of this study was to estimate the rate and significance of colonisation with
vancomycin-resistant enterococci (VRE) among hospitalised children. The PubMed and …

Background. Bloodstream infection (BSI) to due vancomycin-resistant Enterococcus (VRE) is
an important complication of hematologic malignancy. Determining when to use empiric anti …

Bangladesh has experienced a variety of diseases caused by natural dissemination of an
array of pathogenic microorganisms into the environment. While cures for these diseases …

Background Vancomycin-resistant enterococcus (VRE) is an infectious agent that can
increase morbidity and mortality, especially in patients with neutropenia in haematology …

Objectives Multidrug-resistant organisms (MDRO) are considered an emerging threat
worldwide. Data covering the clinical impact of MDRO colonization in patients with solid …

Objectives Vancomycin-resistant enterococci (VRE) pose a major threat in hospital settings.
Patients with cancer are at a higher risk of hospital-acquired infections such as VRE. This …

Background Vancomycin-resistant enterococci (VRE) are well known agents that colonize
the gastrointestinal tract of immunocompromised patients, especially those with hematologic …